MMU is an exciting pharma conducting some promising cannabis elated research, addressing critical areas ilke cancer, ALS, PTSD, etc..
Along wih cannabis stocks focusing on laboratory compliance service to the industry, it doesn't get more hopefully promising than a cannabis research stock and the potentially staggering share price potential they bring.
Immunomedics is one of those stocks and a real buy right now.
IMMU is followed and recommended by major financial firms. The last time i checked, Jeffries and Co. had a price target at something like $7.0.
Portfolio diversification is always very important too the smart invesor and IMM is a great addition. GLTY.
